DNMT1 and gastric cancer: This gives them great potential for overcoming resistance by combination with chemotherapy and radiotherapy in GC treatments.524 In a phase I trial, the DNMT inhibitor 5-azacitidine was added to the neoadjuvant chemotherapy for GC.